Researchers identify potential new strategy to prevent side effects from immunotherapy

Study sheds a light on the cause of endocrine autoimmune diseases (IRAEs) that occur in about 20% of patients treated with checkpoint immunotherapy.

Wonderful collaborating with Dr. Maureen Su and so many others at UCLA and USC.

Just published in Science Translational Medicine:

Press release

Read the Paper